If there’s one thing modern eye care isn’t short on, it’s possibility. So let’s pause and reflect on what that really means in everyday practice.

Optometry is on the brink of a major shift, as discussed in Prescription for change. With GP services under strain and eye clinics plagued by long waiting lists, the government’s consultation on expanding the medicines optometrists and contact lens opticians can supply could be a turning point. If approved, it would move much more eye care into the community, allowing practitioners to diagnose and treat common conditions without unnecessary referrals. It’s widely seen as overdue recognition of optometry’s growing clinical role and could help ease NHS pressure, speed up care and prevent avoidable sight loss. Although timelines and details are uncertain, the direction of travel feels clear: optometrists are becoming an even bigger part of the frontline healthcare solution.

At the same time, technology is pushing boundaries. As described in Reality bites, smart contact lenses are no longer just science fiction – they are now reality. Researchers are exploring lenses that can analyse tears, track eye pressure or release drugs, but most remain firmly in the lab. A few niche tools, such as intraocular pressure-monitoring lenses, show what’s possible, while others, like glucose sensing, have hit practical limits. The most promising early applications are probably in dry eye, inflammation and glaucoma. These innovations won’t transform practice overnight, but incremental, clinically useful advances are on the way.
 

Retinal biomarkers add another layer of opportunity – and complexity – to health insights, as seen in Ride the wave. Biomarkers offer powerful, predictive insights. But they also raise tricky questions: when early indicators appear in an otherwise asymptomatic patient, what’s the right response? Monitor, refer, treat, or explain and reassure? These judgement calls sit right at the heart of modern optometric practice.

By linking eye scans with genetics, lifestyle and environmental data, multiomics could help detect systemic disease earlier and personalise care. Optical coherence tomography images combined with AI and other biomarkers could turn the eye into a window on whole-body health. Optometrists are well placed to lead this shift, particularly when it comes to explaining what these insights mean for patients.

Perhaps the biggest shift isn’t technological, but professional, as discussed in our feature Health vs profit. Modern eye care isn’t about having all the answers; it’s about asking better questions, prioritising wisely and staying adaptable in a fast-moving profession.

Balancing clinical excellence with commercial realities remains a daily tension, but one principle is non-negotiable: if something reduces clinical risk or changes management, it has to be done. Clear communication, supportive leadership and firm boundaries help navigate that balance, because seeing more should ultimately help us care better, not just work harder.

Image credit | Caroline Andrieu